Norwalk virus edible vaccine - Boyce Thompson Institute for Plant Research
Latest Information Update: 24 Oct 2021
At a glance
- Originator Boyce Thompson Institute for Plant Research
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Norwalk virus infections
Most Recent Events
- 05 Sep 2000 The Boyce Thompson Institute is seeking a corporate partner for continued development of the edible Norwalk virus vaccine (http://bti.cornell.edu/)
- 28 Aug 2000 A phase I trial has been added to the adverse events section and the Viral Infections immunogenicity section
- 21 Jun 2000 Phase-I clinical trials for Norwalk virus infections in USA (PO)